Jacqueline M Mason

Title: The Innovative Contributions of Jacqueline M Mason

Introduction

Jacqueline M Mason is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic antibodies. With a total of 9 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents are the inventions related to LILRB3-binding molecules and FCMR-binding molecules. The LILRB3-binding molecules patent provides novel anti-LILRB3 antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods for treating diseases such as cancer, autoimmune diseases, or allergic inflammation. This invention also offers a method to modulate osteoclast differentiation. The FCMR-binding molecules patent similarly introduces novel anti-FCMR antibodies and therapeutic methods for treating cancer and autoimmune diseases.

Career Highlights

Jacqueline M Mason is affiliated with the University Health Network, where she conducts her research and development work. Her innovative approaches and discoveries have positioned her as a key figure in her field, contributing to advancements in medical treatments.

Collaborations

Throughout her career, Jacqueline has collaborated with notable colleagues, including Mark R Bray and Richard Brokx. These partnerships have further enhanced her research capabilities and broadened the impact of her inventions.

Conclusion

Jacqueline M Mason's contributions to the field of biomedical research through her innovative patents demonstrate her commitment to advancing medical science. Her work continues to pave the way for new therapeutic options for patients worldwide.